Fibreoptic bronchoscopy and anti-platelet agents: A risk-benefit analysis;Bronchoscopie souple et antiagrégants plaquettaires: Analyse du rapport bénéfices-risques

Revue des Maladies Respiratoires

Volumn 24, Issue 1, 2007, Pages 48-56

  Trosini Desert V ^a   Vergnon, J M ^b   Collet, J P ^a   Montalescot, G ^a   Similowski, T ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Anti platelet agents; Bronchoscopy; Haemorrhage; Ischaemic heart disease; Risk benefit analysis; Thrombosis

Indexed keywords

ANTITHROMBOCYTIC AGENT; PACLITAXEL; RAPAMYCIN;

ARTICLE; BLEEDING; BRONCHOSCOPY; CLINICAL PRACTICE; HEALTH SURVEY; HUMAN; PRACTICE GUIDELINE; RISK ASSESSMENT; THROMBOSIS;

EID: 33846820264     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(07)91011-6     Document Type: Article

References (36)

1. Chinsky K : Bleeding risk and bronchoscopy: in search of the evidence in evidence-based medicine. Chest 2005 ; 127 : 1875-7.
2. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R : RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002 ; 346 : 1773-80.
3. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A : Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005 ; 293 : 2126-30.
4. Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlocker T, Charnoff NE, Melby S, Berger PB : Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003 Jul 16 ; 42 : 234-40.
5. Cordasco EM Jr, Mehta AC, Ahmad M : Bronchoscopically induced bleeding. A summary of nine years' Cleveland clinic experience and review of the literature. Chest 1991 ; 100 : 1141-7.
6. British Thoracic Society Bronchoscopy Guidelines Committee, a Subcommittee of Standards of Care Committee of British Thoracic Society. British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax 2001 ; 56: S11-S21.
7. Zahreddine I, Atassi K, Fuhrman C, Febvre M, Maitre B, Housset B : Impact of prior biological assessment of coagulation on the hemorrhagic risk of fiberoptic bronchoscopy. Rev Mal Respir 2003 ; 20 : 341-6.
8. Agents antiplaquettaires et période péri-opératoire. Conférence d'experts : Société Française d'Anesthésie et de Réanimation, Groupe d'étude sur l'hémostase et la thrombose de la Société Française d'Hématologie. Paris Elsevier 2002 ; 7-139.
9. Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G : Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 ; 126 : 234S-264S.
10. Samama CM, Djoudi R, Lecompte T, Nathan-Denizot N, Schved JF : Agence Francaise de Securite Sanitaire des Produits de Sante expert group. Perioperative platelet transfusion: recommendations of the Agence Francaise de Sécurite Sanitaire des Produits de Sante (AFS-SAPS) 2003. Can J Anaesth 2005 ; 52 : 30-7.
11. FitzGerald GA, Oates JA, Hawiger J, Maas RL, Roberts LJ 2nd, Lawson JA, Brash AR : Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest 1983 ; 71 : 676-88.
12. Brochier ML : Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarction. The Flurbiprofen French Trial. Eur Heart J 1993 ; 14 : 951-7.
13. Herth FJ, Becker HD, Ernst A : Aspirin does not increase bleeding complications after transbronchial biopsy. Chest 2002 ; 122 : 1461-4.
14. Hittelet A, Deviere J : Management of anticoagulants before and after endoscopy. Can J Gastroenterol 2003 ; 17 : 329-32.
15. Yousfi M, Gostout CJ, Baron TH, Hernandez JL, Keate R, Fleischer DE, Sorbi D : Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol 2004 ; 99 : 1785-9.
16. CAPRIE Steering Committee : A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 1996 ; 348 : 1329-39.
17. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, Lewis BS, Murphy SA, McCabe CH, Braunwald E : Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA 2005 ; 294 : 1224-32.
18. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ : CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. JAMA 2002 ; 288 : 2411-20.
19. The CURE Investigators : Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Eng J Med 2001 ; 345 : 494-502.
20. Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, Collins R, Liu LS : COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005 ; 366 : 1607-21.
21. Payne DA, Hayes PD, Jones CI, Belham P, Naylor AR, Goodall AH : Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action. J Vasc Surg 2002 ; 35 : 1204-9.
22. Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S : Clopidogrel in unstable angina to prevent recurrent ischemic events trial. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome the clopidogrel in unstable angina to prevent recurrent ischemic events (CURE) trial. Circulation 2004 ; 110 : 1202-8.
23. Cannon CP, Mehta SR, Aranki SF : Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery. Ann Thorac Surg 2005 ; 80 : 768-79.
24. Collet JP, Montalescot G : L'arrêt des antiagrégants plaquettaires : est-ce le problème des cardiologues ? La Lettre du Cardiologue 2005 ; 385 : 3-4.
25. Wahidi MM, Garland R, Feller-Kopman D, Herth F, Becker HD, Ernst A : Effect of clopidogrel with and without aspirin on bleeding following transbronchial lung biopsy. Chest 2005 ; 127 : 961-4.
26. Wahidi M, Becker HD, Herth FJ : Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest 2006 ; 129 : 734-7.
27. Cadroy Y, Thalamas C, Sakariassen K, Boneu B : Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers. Thromb Res 2005 ; 116 : 293-300.
28. Collet JP, Himbert F, Steg PG : Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol 2000 ; 76 : 257-8.
29. Collet JP, Montalescot G, Blanchet B, Tanguy ML, Golmard JL, Choussat R, Beygui F, Payot L, Vignolles N, Metzger JP, Thomas D : Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004 19 ; 110 : 2361-7.
30. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE : Catastrophic outcomes of non cardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000 ; 35 : 1288-94.
31. Orford JL, Lennon R, Melby S, Fasseas P, Bell MR, Rihal CS, Holmes DR, Berger PB : Frequency and correlates of coronary stent thrombosis in the modern era : analysis of a single center registry. J Am Coll Cardiol 2002 6 ; 40 : 1567-72.
32. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ, Kuntz RE : A clinical trial comparing three antithromboticdrug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998 ; 339 : 1665-71.
33. Decoene C, Vincentelli A, Fabre O, Crepin F, Pol A : Late thrombosis of a drug-eluting coronary stent after antiplatelet therapy discontinuation. Ann Fr Anesth Reanim 2005 ; 24 : 1275-7.
34. Waksman R, Ajani AE, White RL, Pinnow E, Dieble R, Bui AB, Taaffe M, Gruberg L, Mintz GS, Satler LF, Pichard AD, Kent KK, Lindsay J : Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS). Circulation 2001 15 ; 103 : 2332-5.
35. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, Pierpont G, Santilli S, Rapp J, Hattler B, Shunk K, Jaenicke C, Thottapurathu L, Ellis N, Reda DJ, Henderson WG : Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004 ; 351 : 2795-804.
36. Napoleon B, Boneu B, Maillard L, Samama CM, Schved JF, Gay G, Ponchon T, Sautereau D, Canard JM : Guidelines of the French Society for Digestive Endoscopy (SFED). Endoscopy 2006 Mar 14.